Estimate Recalculated Nov 7, 2024 04:56PM EST
Timothy P Walbert has an estimated net worth of $281 Million. This is based on reported shares across multiple companies, which include HORIZON PHARMA, INC., Aurinia Pharmaceuticals Inc., Sucampo Pharmaceuticals, Inc., XOMA LTD /DE/, Egalet Corp, Mirum Pharmaceuticals, Inc., EXICURE, INC., Assertio Holdings, Inc., Century Therapeutics, Inc., Raptor Pharmaceutical Corp, NEOPHARM INC, IDM PHARMA, INC., and Sagimet Biosciences Inc..
Timothy P Walbert's CIK is 0001349376
2014 was Timothy P Walbert's most active year for acquiring shares with 25 total transactions. Timothy P Walbert's most active month to acquire stocks was the month of December. 2022 was Timothy P Walbert's most active year for disposing of shares, totalling 55 transactions. Timothy P Walbert's most active month to dispose stocks was the month of December. 2019 saw Timothy P Walbert paying a total of $1,814,878.82 for 995,846 shares, this is the most they've acquired in one year. In 2023 Timothy P Walbert cashed out on 4,010,276 shares for a total of $88,166,758.64, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!